Protein-protein interactions occur between p53 phosphoforms and ATM and 53BP1 at sites of exogenous DNA damage

Radiation Research

Volumn 175, Issue 5, 2011, Pages 588-598

  Al Rashid, Shahnaz T ^a,b,d   Harding, Shane M ^a,c   Law, Cindy ^a   Coackley, Carla ^c   Bristow, Robert G ^a,b,c  

^a Department of Medical Biophysics ^*  (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CARBOXYL GROUP; HYBRID PROTEIN; PROTEIN P53; SERINE;

ARTICLE; CHROMATIN; DNA BINDING; DNA DAMAGE; ENZYME ACTIVITY; FIBROBLAST; FLUORESCENCE MICROSCOPY; GENE DELETION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; ULTRAVIOLET RADIATION;

CELL CYCLE PROTEINS; CELL LINE; CHROMATIN; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE DELETION; SERINE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 79955413060     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR2084.1     Document Type: Article

References (43)

1. C. J. Bakkenist and M. B. Kastan, DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506 (2003). (Pubitemid 36168436)
2. M. B. Kastan and E. Berkovich, p53: a two-faced cancer gene. Nat. Cell Biol. 9, 489-491 (2007).
3. E. Berkovich, R. J. Monnat, Jr. and M. B. Kastan, Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair. Nat. Cell Biol. 9, 683-690 (2007). (Pubitemid 47214731)
4. Y. C. Kim, G. Gerlitz, T. Furusawa, F. Catez, A. Nussenzweig, K. S. Oh, K. H. Kraemer, Y. Shiloh and M. Bustin, Activation of ATM depends on chromatin interactions occurring before induction of DNA damage. Nat. Cell Biol. 11, 92-96 (2009).
5. M. F. Lavin and N. Gueven, The complexity of p53 stabilization and activation. Cell Death Differ. 13, 941-950 (2006).
6. A. J. Levine, W. Hu and Z. Feng, The P53 pathway: what questions remain to be explored? Cell Death Differ. 13, 1027-1036 (2006).
7. U. M. Moll, S. Wolff, D. Speidel and W. Deppert, Transcriptionindependent pro-apoptotic functions of p53. Curr. Opin. Cell Biol. 17, 631-636 (2005).
8. J. E. Chipuk, T. Kuwana, L. Bouchier-Hayes, N. M. Droin, D. D. Newmeyer, M. Schuler and D. R. Green, Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010-1014 (2004). (Pubitemid 38209704)
9. A. Restle, M. Farber, C. Baumann, M. Bohringer, K. H. Scheidtmann, C. Muller-Tidow and L. Wiesmuller, Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants. Nucleic Acids Res. 36, 5362-5375 (2008).
10. S. A. Gatz and L. Wiesmuller, p53 in recombination and repair. Cell Death Differ. 13, 1003-1016 (2006).
11. J. Dahm-Daphi, P. Hubbe, F. Horvath, R. A. El-Awady, K. E. Bouffard, S. N. Powell and H. Willers, Nonhomologous endjoining of site-specific but not of radiation-induced DNA doublestrand breaks is reduced in the presence of wild-type p53. Oncogene 24, 1663-1672 (2005). (Pubitemid 40461123)
12. R. G. Bristow, Q. Hu, A. Jang, S. Chung, J. Peacock, S. Benchimol and R. Hill, Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DSB rejoining during exposure to ionizing radiation. Oncogene 16, 1789-1802 (1998). (Pubitemid 28197399)
13. P. Bertrand, Y. Saintigny and B. S. Lopez, p53's double life: transactivation-independent repression of homologous recombination. Trends Genet. 20, 235-243 (2004). (Pubitemid 38625681)
14. N. A. Lanson, Jr., D. B. Egeland, B. A. Royals and W. C. Claycomb, The MRE11-NBS1-RAD50 pathway is perturbed in SV40 large T antigen-immortalized AT-1, AT-2 and HL-1 cardiomyocytes. Nucleic Acids Res. 28, 2882-2892 (2000). (Pubitemid 30599262)
15. S. P. Linke, S. Sengupta, N. Khabie, B. A. Jeffries, S. Buchhop, S. Miska, W. Henning, R. Pedeux, X. W. Wang and C. C. Harris, p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res. 63, 2596-2605 (2003). (Pubitemid 36605201)
16. A. Albor, S. Kaku and M. Kulesz-Martin, Wild-type and mutant forms of p53 activate human topoisomerase I: a possible mechanism for gain of function in mutants. Cancer Res. 58, 2091-2094 (1998). (Pubitemid 28232891)
17. H. Song, M. Hollstein and Y. Xu, p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat. Cell Biol. 9, 573-580 (2007). (Pubitemid 46696539)
18. J. E. FitzGerald, M. Grenon and N. F. Lowndes, 53BP1: function and mechanisms of focal recruitment. Biochem. Soc. Trans. 37, 897-904 (2009).
19. K. A. Wilson and D. F. Stern, NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway. Cell Cycle 7, 3584-3594 (2008).
20. H. Lee, H. J. Kwak, I. T. Cho, S. H. Park and C. H. Lee, S1219 residue of 53BP1 is phosphorylated by ATM kinase upon DNA damage and required for proper execution of DNA damage response. Biochem. Biophys. Res. Commun. 378, 32-36 (2009).
21. K. Iwabuchi, P. L. Bartel, B. Li, R. Marraccino and S. Fields, Two cellular proteins that bind to wild-type but not mutant p53. Proc. Natl. Acad. Sci. USA 91, 6098-6102 (1994). (Pubitemid 24188290)
22. D. J. Derbyshire, B. P. Basu, L. C. Serpell, W. S. Joo, T. Date, K. Iwabuchi and A. J. Doherty, Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J. 21, 3863-3872 (2002). (Pubitemid 34787058)
23. S. Roy, C. A. Musselman, I. Kachirskaia, R. Hayashi, K. C. Glass, J. C. Nix, O. Gozani, E. Appella and T. G. Kutateladze, Structural insight into p53 recognition by the 53BP1 tandem Tudor domain. J. Mol. Biol. 398, 489-496 (2010).
24. S. Bekker-Jensen, C. Lukas, R. Kitagawa, F. Melander, M. B. Kastan, J. Bartek and J. Lukas, Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J. Cell Biol. 173, 195-206 (2006).
25. K. Iwabuchi, B. P. Basu, B. Kysela, T. Kurihara, M. Shibata, D. Guan, T. Cao, T. Hamada, K. Imamura and A. J. Doherty, Potential role for 53BP1 in DNA end-joining repair through direct interaction with DNA. J. Biol. Chem. 278, 36487-36495 (2003). (Pubitemid 37139978)
26. A. Xie, A. Hartlerode, M. Stucki, S. Odate, N. Puget, A. Kwok, G. Nagaraju, C. Yan, F. W. Alt and R. Scully, Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair. Mol. Cell 28, 1045-1057 (2007). (Pubitemid 350297033)
27. A. T. Noon, A. Shibata, N. Rief, M. Lobrich, G. S. Stewart, P. A. Jeggo and A. A. Goodarzi, 53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair. Nat. Cell Biol. 12, 177-184 (2010).
28. M. Sauer, A. C. Bretz, R. Beinoraviciute-Kellner, M. Beitzinger, C. Burek, A. Rosenwald, G. S. Harms and T. Stiewe, C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity. Nucleic Acids Res. 36, 1900-1912 (2008). (Pubitemid 351494234)
29. A. Ayed, F. A. Mulder, G. S. Yi, Y. Lu, L. E. Kay and C. H. Arrowsmith, Latent and active p53 are identical in conformation. Nat. Struct. Biol. 8, 756-760 (2001). (Pubitemid 32803591)
30. A. Tafvizi, F. Huang, J. S. Leith, A. R. Fersht, L. A. Mirny and A. M. van Oijen, Tumor suppressor p53 slides on DNA with low friction and high stability. Biophys. J. 95, L01-L03 (2008).
31. P. Hinow, C. E. Rogers, C. E. Barbieri, J. A. Pietenpol, A. K. Kenworthy and E. DiBenedetto, The DNA binding activity of p53 displays reaction-diffusion kinetics. Biophys. J. 91, 330-342 (2006). (Pubitemid 44015330)
32. H. Pivonkova, M. Brazdova, J. Kasparkova, V. Brabec and M. Fojta, Recognition of cisplatin-damaged DNA by p53 protein: critical role of the p53 C-terminal domain. Biochem. Biophys. Res. Commun. 339, 477-484 (2006). (Pubitemid 41739692)
33. W. Tang, H. Willers and S. N. Powell, p53 directly enhances rejoining of DNA double-strand breaks with cohesive ends in gamma-irradiated mouse fibroblasts. Cancer Res. 59, 2562-2565 (1999). (Pubitemid 29269098)
34. M. Reed, B. Woelker, P. Wang, Y. Wang, M. E. Anderson and P. Tegtmeyer, The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc. Natl. Acad. Sci. USA 92, 9455-9459 (1995).
35. S. T. Al Rashid, G. Dellaire, A. Cuddihy, F. Jalali, M. Vaid, C. Coackley, M. Folkard, Y. Xu, B. P. Chen and R. G. Bristow, Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo. Cancer Res. 65, 10810-10821 (2005). (Pubitemid 41713348)
36. L. Y. Romanova, H. Willers, M. V. Blagosklonny and S. N. Powell, The interaction of p53 with replication protein A mediates suppression of homologous recombination. Oncogene 23, 9025-9033 (2004). (Pubitemid 40013069)
37. R. G. Bristow, J. Peacock, A. Jang, J. Kim, R. P. Hill and S. Benchimol, Resistance to DNA-damaging agents is discordant from experimental metastatic capacity in MEF rastransformants- expressing gain of function MTp53. Oncogene 22, 2960-2966 (2003). (Pubitemid 36648923)
38. G. Matlashewski, P. Lamb, D. Pim, J. Peacock, L. Crawford and S. Benchimol, Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. EMBO J. 3, 3257-3262 (1984).
39. N. Chan, M. Koritzinsky, H. Zhao, R. Bindra, P. M. Glazer, S. Powell, A. Belmaaza, B. Wouters and R. G. Bristow, Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res. 68, 605-614 (2008). (Pubitemid 351380090)
40. J. D. Dignam, R. M. Lebovitz and R. G. Roeder, Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489 (1983).
41. A. R. Cuddihy, F. Jalali, C. Coackley and R. G. Bristow, WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells. Mol. Cancer Ther. 7, 980-992 (2008). (Pubitemid 351551052)
42. M. M. Sugrue, D. Y. Shin, S. W. Lee and S. A. Aaronson, Wildtype p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA 94, 9648-9653 (1997). (Pubitemid 27408116)
43. S. Sengupta, A. I. Robles, S. P. Linke, N. I. Sinogeeva, R. Zhang, R. Pedeux, I. M. Ward, A. Celeste, A. Nussenzweig and C. C. Harris, Functional interaction between BLM helicase and 53BP1 in a Chk1-mediated pathway during S-phase arrest. J. Cell Biol. 166, 801-813 (2004). (Pubitemid 39249832)